CV Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
CV Therapeutics, Inc. is a biopharmaceutical company based in Palo Alto, California, focused on developing novel small molecule therapeutics for cardiovascular diseases. Its work aims to provide new treatment options within cardiovascular medicine, addressing unmet clinical needs in this area. The company operates within the biotechnology research industry and has grown to a sizable workforce to support its research and development activities. In April 2009, CV Therapeutics was acquired by Gilead Sciences, with ongoing involvement from former leadership in a senior advisory capacity through 2019. A recent development noted in industry reporting is that Gilead acquired CV Therapeutics for a substantial sum on an earlier date, reflecting a strategic integration within a larger biopharmaceutical portfolio.